| Primary |
| Rosacea |
61.0% |
| Hypertension |
6.1% |
| Acne |
3.7% |
| Dermatitis |
3.7% |
| Drug Use For Unknown Indication |
3.7% |
| Product Used For Unknown Indication |
3.7% |
| Pain |
2.4% |
| Contraception |
1.2% |
| Dry Eye |
1.2% |
| Erythema |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Gout |
1.2% |
| Hormone Replacement Therapy |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Hypersensitivity |
1.2% |
| Mineral Supplementation |
1.2% |
| Prehypertension |
1.2% |
| Psoriasis |
1.2% |
| Rash |
1.2% |
| Seborrhoeic Dermatitis |
1.2% |
|
| Clostridium Difficile Colitis |
13.2% |
| Migraine |
7.9% |
| Nausea |
7.9% |
| Diarrhoea |
5.3% |
| Diverticulitis |
5.3% |
| Gastric Disorder |
5.3% |
| Hypertension |
5.3% |
| Loss Of Consciousness |
5.3% |
| Pancreatitis |
5.3% |
| Pseudomembranous Colitis |
5.3% |
| Tinnitus |
5.3% |
| Urinary Retention |
5.3% |
| Viral Infection |
5.3% |
| Activities Of Daily Living Impaired |
2.6% |
| Anaphylactic Reaction |
2.6% |
| Angioedema |
2.6% |
| Anxiety |
2.6% |
| Chest Pain |
2.6% |
| Clostridium Difficile Infection |
2.6% |
| Condition Aggravated |
2.6% |
|
| Secondary |
| Rosacea |
31.0% |
| Hypertension |
23.8% |
| Product Used For Unknown Indication |
11.9% |
| Acne |
4.8% |
| Gout |
4.8% |
| Hypercholesterolaemia |
4.8% |
| Supplementation Therapy |
4.8% |
| Contraception |
2.4% |
| High Density Lipoprotein Decreased |
2.4% |
| Hypothyroidism |
2.4% |
| Low Density Lipoprotein Increased |
2.4% |
| Mineral Supplementation |
2.4% |
| Skin Wrinkling |
2.4% |
|
| Drug Ineffective |
18.2% |
| Benign Intracranial Hypertension |
9.1% |
| Facial Pain |
9.1% |
| Muscular Weakness |
9.1% |
| Nausea |
9.1% |
| Off Label Use |
9.1% |
| Rash |
9.1% |
| Skin Irritation |
9.1% |
| Vision Blurred |
9.1% |
| Weight Bearing Difficulty |
9.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.1% |
| Rosacea |
10.6% |
| Supplementation Therapy |
7.7% |
| Hypertension |
4.0% |
| Psoriasis |
4.0% |
| Acne |
3.3% |
| Arthritis |
3.3% |
| Multiple Sclerosis |
3.3% |
| Prophylaxis |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Drug Use For Unknown Indication |
2.6% |
| Fibromyalgia |
2.6% |
| Atrial Fibrillation |
2.2% |
| Migraine Prophylaxis |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Blood Cholesterol Increased |
1.5% |
| Constipation |
1.5% |
| Diabetes Mellitus |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Headache |
1.5% |
|
| Vomiting |
11.4% |
| Headache |
9.1% |
| Gingival Pain |
6.8% |
| Nasopharyngitis |
6.8% |
| Application Site Dryness |
4.5% |
| Drug Ineffective |
4.5% |
| Feeling Abnormal |
4.5% |
| Herpes Zoster |
4.5% |
| Hospitalisation |
4.5% |
| Injection Site Pain |
4.5% |
| Intraocular Pressure Increased |
4.5% |
| Pain |
4.5% |
| Pneumonia |
4.5% |
| Respiratory Depression |
4.5% |
| Rosacea |
4.5% |
| Therapy Cessation |
4.5% |
| Weight Decreased |
4.5% |
| Abdominal Distension |
2.3% |
| Alopecia |
2.3% |
| Ankylosing Spondylitis |
2.3% |
|
